METTL5 may influence the translation of key immune modulators, including cytokines, co-stimulatory molecules, or immunosuppressive factors, thereby affecting immune infiltration, anti-tumor immunity, and immunotherapy responsiveness. The gene discussed is METTL5; the disease is neoplasm.